Dr. Inmaculada Gómez Arrayás
Address: Ruber Internacional Hospital Calle de la Masó, 38, Madrid, Madrid, Comunidad de, Spain
Gender: Female
About the Doctor / Professional
Dr. Inmaculada Gómez Arrayás is a specialist in orthopedic surgery and traumatology, with extensive experience in joint replacement surgery, having performed over 3,500 hip and knee prostheses. She heads the Traumatology and Orthopedic Unit at Rúber Internacional Hospital. She is a pioneer in performing surgeries using navigation systems and rapid recovery techniques.
Degree: Autonomous University of Madrid - 1992
Residency: Puerta de Hierro Hospital - Madrid
- 2018-present| Head of the Traumatology and Orthopedic Unit at Ruber International in Madrid
- 2000-2018| Traumatologist specializing in Hip and Knee Surgery at H. Ruber Internacional in Madrid
- 2000| Deputy Head of Traumatology at H. Puerta de Hierro in Madrid
- 2022 | Forbes List: as one of the 100 best doctors in Spain (a leading figure and pioneer in Spain in joint replacement surgery with navigation systems)
- Since 2008 | ISO 9001:2008 quality certification for hip and knee replacement procedures.
- Año|Phase 2B, randomized, multicenter, dose-finding study to evaluate the safety and efficacy of PD 0348292 in the prevention of venous thromboembolic events (VTE) in subjects undergoing elective unilateral total knee arthroplasty (protocol A5571010)
- Año|Estudio CV185-047 to evaluate APIXABAN dosed orally versus anticoagulation with injectable ENOXAPARIN to prevent venous thromboembolism.Año|CV185-035 of an investigational Drug for the Prevention of DVT Following Hip Replacement Surgery.
- Añp|Estudio 1160.85 to evaluate the safety and efficacy of PRADAXA® (dabigatran etexilate) for the prevention of venous thromboembolism in patients undergoing elective total hip replacement surgery or total knee replacement surgery in a routine clinical setting.
- Año|Study 1160.84 to evaluate the safety and efficacy of PRADAXA® (dabigatran etexilate) in patients with moderate renal impairment (creatinine clearance 30- 50 ml/min) undergoing elective total hip replacement surgery or total knee replacement surgery.
- Año|CV185-035 of an investigational Drug for the Prevention of DVT Following Hip Replacement Surgery.
- Hip Surgery
- Joint Replacement
- Knee Surgery
- Orthopedics Consultation
- Trauma Management
- Trauma Surgery
- Traumatology
- International Member of the American Academy of Orthopedic Surgeons
- Member of the Spanish Arthroscopy Association
